Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

In a world where respiratory issues are increasingly common, finding practical solutions can be daunting. Breathe Drops ...

Chronic pain is a common complaint among those with COPD. Columnist Caroline Gainer shares the pain relief strategies that ...